CD274 and non-small cell lung carcinoma: Similar constellations have been previously described in several other entities including non-small cell lung cancer, where dual checkpoint inhibition with nivolumab and ipilimumab significantly prolonged PFS and OS particularly in patients with high TMB regardless of PD-L1 expression17,64,65.